LUVIS – LUVIS PLUS – LUVIS LIPO : HYALURONIC ACID 0.10%, 0.15%, 0.2%, 0.4% (OPHTHALMOLOGY - DRY EYE)

LUVIS – LUVIS PLUS – LUVIS LIPO : HYALURONIC ACID 0.10%, 0.15%, 0.2%, 0.4% (OPHTHALMOLOGY - DRY EYE)
Product Description

NTC S.r.l. offers a wide range of ophthalmic medical devices which includes hyaluronic acid at different dosages 0.10%, 0.15%, 0.2%, 0.4% and the addition of other components.
LUVIS:  Hyaluronic Acid eye drop solution is the ideal product for instantly soothing and hydrating dry eyes. Sodium Hyaluronate improves the tear film stability and keeps the ocular surface comfortable, lubricated, hydrated and protected.
LUVIS PLUS is designed to protect the eye for a long period due to its composition containing a high concentration of sodium hyaluronate, levocarnitine (osmoprotector) and zinc.
LUVIS LIPO is designed to protect the eye for a long period during the day and the night due to high concentration of sodium hyaluronate, levocarnitine (osmoprotector) and castor oil (restore lipid layer). 1 scientific publication available.

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
Specifications
  • Selling Points
    Product Performance
  • Supplied from
    Italy

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from NTC S.r.l. (29)

NTC S.r.l. resources (1)

  • Brochure Therapeutical areas - brochure

    Advanced scientific research and technology drive our efforts to innovate care practices.
    Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
    An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
    Our research aims to put pioneering new products within the reach of everyone and to optimize the
    performance of our products by analyzing the daily needs and habits of people undergoing treatment.
    We research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
    Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.